Download or read book Report of a Meeting on the Development of Drugs Against African Trypanosomiasis Leishmaniasis and Chagas Disease written by and published by . This book was released on 1990 with total page 24 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Discovery and Development of Drugs for Neglected Diseases Chagas Disease Human African Trypanosomiasis and Leishmaniasis written by Gildardo Rivera and published by Frontiers Media SA. This book was released on 2021-12-20 with total page 171 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Research Priorities for Chagas Disease Human African Trypanosomiasis and Leishmaniasis written by World Health Organization and published by . This book was released on 2012 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Disease Reference Group on Chagas Disease Human AfricanTrypanosomiasis and Leishmaniasis (DRG3) was part of an independent thinktankof international experts established by the Special Programme for Researchand Training in Tropical Diseases (TDR) to identify key research prioritiesthrough systematic review of research evidence and input from stakeholders. These three distinct insect-borne diseases while caused by related kinetoplastidprotozoan pathogens have dissimilar geographical distributions a reflection oftheir different insect vectors and range of vector contact with humans. Thedisease.
Download or read book Research Priorities for Chagas Disease Human African Trypanosomiasis and Leishmaniasis written by TDR Disease Reference Group on Chagas Disease, Human African Trypanosomiasis and Leishmaniasis and published by WHO Technical Report. This book was released on 2012 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: "This report provides a review and analysis of the research landscape for three diseases--Chagas disease, human African Trypanosomiasis and leishmaniasis--that dispropotionally afflict poor and remote populations with limited access to health services. It represents the work of the disease reference group on Chagas Disease, human African Trypanosomiasis, and leishmaniasis (DRG3) which was established to identify key research priorities through review of research evidence and input from stakeholders' consultations. The diseases, which are caused by related protozoan parasites, are described in terms of their epidemiology and disease burden, clinical forms and pathogenesis, HIV coinfection, diagnosis, drugs and drug resistance, vaccines, vector control, and health-care interventions. Priority areas for research are identified based on criteria such as public health relevance, benefit and impact on poor populations and equity, and feasibility. The priorities are found in the areas of diagnostics, drugs, vector control, asymptomatic infection, economic analysis of treatment and vector control methods, and in some specific issues such as surveillance methods or transmission-blocking vaccines for particular diseases. This report will be useful to researchers, policy and decision makers, funding bodies, implementation organizations, and civil society."--P. 4 of cover.
Download or read book Biochemical Protozoology As A Basis For Drug Design written by Graham H. Coombs and published by CRC Press. This book was released on 1991-10-07 with total page 656 pages. Available in PDF, EPUB and Kindle. Book excerpt: A compilation of articles on protozoological biochemistry which reviews the subject area and offers information on current research. Included in the Topics Covered Are Energy Metabolism Of Anaerobic Parasitic Protists, proteinases of African
Download or read book Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases written by World Health Organization and published by World Health Organization. This book was released on 2013 with total page 153 pages. Available in PDF, EPUB and Kindle. Book excerpt: "Produced under the overall direction and supervision of Dr. Lorenzo Savioli (Director) and Dr. Denis Daumerie (Programme Manager), WHO Department of Control of Neglected Tropical Diseases"--Back of title page.
Download or read book Approaches to Design and Synthesis of Antiparasitic Drugs written by N. Anand and published by Elsevier. This book was released on 1997-07-10 with total page 525 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book presents a comprehensive and up to date account of the chemotherapy of parasitic diseases, both human and veterinary. The book starts with an overview of parasitic diseases. The body of the book is divided into two parts: antihelminthic drugs, and antiprotozoal drugs. Both parts start with chapters highlighting the 'biochemical targets' available for chemotherapeutic interference. Individual chapters deal with one chemical class of compounds and describe their origin, structure-activity relationship, mode of action, and methods of synthesis and their status both in clinical and veterinary practice. The book will be useful to a wide spectrum of readers: students embarking on a research career in parasitic chemotherapy, clinicians (and veterinarians) and clinical pharmacologists desiring detailed information about the drugs currently in use, and pharmaceutical technologists wanting to update their knowledge of the methods of manufacture.
Download or read book Investing to Overcome the Global Impact of Neglected Tropical Diseases written by World Health Organization and published by World Health Organization. This book was released on 2015-08-05 with total page 211 pages. Available in PDF, EPUB and Kindle. Book excerpt: "The presence, or absence, of neglected tropical diseases (NTDs) can be seen as a proxy for poverty and for the success of interventions aimed at reducing poverty. Today, coverage of the public-health interventions recommended by the World Health Organization (WHO) against NTDs may be interpreted as a proxy for universal health coverage and shared prosperity - in short, a proxy for coverage against neglect. As the world's focus shifts from development to sustainable development, from poverty eradication to shared prosperity, and from disease-specific goals to universal health coverage, control of NTDs will assume an important role towards the target of achieving universal health coverage, including individual financial risk protection. Success in overcoming NTDs is a "litmus test" for universal health coverage against NTDs in endemic countries. The first WHO report on NTDs (2010) set the scene by presenting the evidence for how these interventions had produced results. The second report (2013) assessed the progress made in deploying them and detailed the obstacles to their implementation. This third report analyses for the first time the investments needed to achieve the scale up of implementation required to achieve the targets of the WHO Roadmap on NTDs and universal coverage against NTDs. INVESTING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES presents an investment strategy for NTDs and analyses the specific investment case for prevention, control, elimination and eradication of 12 of the 17 NTDs. Such an analysis is justified following the adoption by the Sixty-sixth World Health Assembly in 2013 of resolution WHA6612 on neglected tropical diseases, which called for sufficient and predictable funding to achieve the Roadmap's targets and sustain control efforts. The report cautions, however, that it is wise investment and not investment alone that will yield success. The report registers progress and challenges and signals those that lie ahead. Climate change is expected to increase the spread of several vector-borne NTDs, notably dengue, transmission of which is directly influenced by temperature, rainfall, relative humidity and climate variability primarily through their effects on the vector. Investments in vector-borne diseases will avoid the potentially catastrophic expenditures associated with their control. The presence of NTDs will thereby signal an early warning system for climate-sensitive diseases. The ultimate goal is to deliver enhanced and equitable interventions to the most marginalized populations in the context of a changing public-health and investment landscape to ensure that all peoples affected by NTDs have an opportunity to lead healthier and wealthier lives."--Publisher's description.
Download or read book Trypanosomiasis and Leishmaniasis with Special Reference to Chagas Disease written by Katherine May Elliott and published by Elsevier Publishing Company. This book was released on 1974 with total page 376 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Report of the third WHO stakeholders meeting on gambiense human African trypanosomiasis elimination Geneva Switzerland 18 20 April 2018 written by and published by World Health Organization. This book was released on 2020-03-30 with total page 74 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Trypanosomiasis and Leishmaniasis written by Katherine Elliott and published by . This book was released on 1974 with total page 353 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Chagas Disease written by and published by . This book was released on 1992 with total page 294 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Tsetse and Trypanosomiasis Information Quarterly written by and published by . This book was released on 1990 with total page 598 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Report of the fifth WHO stakeholders meeting on gambiense and rhodesiense human African trypanosomiasis elimination Geneva Switzerland 7 9 June 2023 written by World Health Organization and published by World Health Organization. This book was released on 2024-05-03 with total page 111 pages. Available in PDF, EPUB and Kindle. Book excerpt: Concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypanosomiasis (HAT). As a consequence, the disease was targeted for elimination as a public health problem by 2020. The Sixty-sixth World Health Assembly endorsed this goal in resolution WHA66.12 on Neglected tropical diseases, adopted in 2013. National sleeping sickness control programmes (NSSCPs) are core to progressing in the control of the disease and in adapting to the different epidemiological situations. The involvement of different partners, as well as the support and trust of long-term donors, has been crucial for these achievements. More than 20 years of partnership among WHO, Sanofi and Bayer have enabled WHO to strengthen and sustain financial, technical and material support for the implementation of control activities in countries where HAT is endemic. The long-term support from the Government of Belgium, the Bill & Melinda Gates Foundation (BMGF) and other research institutions in the Democratic Republic of the Congo (DRC) has also been essential. WHO convened the fifth stakeholders meeting on the elimination of HAT due to infection with Trypanosoma brucei gambiense (g-HAT) and Trypanosoma brucei rhodesiense (r-HAT) in Geneva, Switzerland, on 7–9 June 2023. The meeting was held again in person after the coronavirus disease (COVID-19) pandemic and jointly for both forms of the disease. The previous meetings on g-HAT held in 2014, 2016 and 2018, as well as on r-HAT in 2015, 2017 and 2019, and jointly for g-HAT and r-HAT in 2021 (8) reinforced the partnership and commitment for HAT elimination and structured the mechanisms of collaboration within the WHO network for HAT elimination. The network includes NSSCPs, groups developing new tools, international and nongovernmental organizations involved in disease control, and donors. Fewer than 1000 cases of HAT annually have been reported over the past 5 years, which is a historic achievement. The area at risk has been substantially reduced. The elimination of HAT as a public health problem at the global level has been achieved. The new road map for neglected tropical diseases (NTDs) 2021−2030 (“the road map”) with the target to interrupt the transmission of g-HAT requires the strengthened and sustained efforts of all stakeholders, national authorities and partners, under WHO coordination. It will take disproportionally high efforts and innovative strategies to find the last cases of g-HAT and neutralize its transmission. Given the limited resources and other competing public health priorities, this is a challenge that requires our joint commitment.
Download or read book ACCIS Guide to United Nations Information Sources on Health written by United Nations and published by . This book was released on 1992 with total page 244 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Tropical Disease Research written by and published by . This book was released on 1999 with total page 68 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Brazilian Journal of Medical and Biological Research written by and published by . This book was released on 1993-10 with total page 430 pages. Available in PDF, EPUB and Kindle. Book excerpt:
